Eribulin, a simplified ketone analog of the tubulin inhibitor halichondrin B, for the potential treatment of cancer
{{output}}
Eisai Co Ltd is developing eribulin, a simplified synthetic macrocyclic ketone analog of the tubulin inhibitor halichondrin B, for the potential treatment of cancer. Phase III trials are underway in the US and Europe for patients with breast cancer. Eribulin i... ...
